Factors affecting 18F FDOPA standardized uptake value in patients with primary brain tumors after treatment-Reference-Cited by-同舟云学术

Factors affecting 18F FDOPA standardized uptake value in patients with primary brain tumors after treatment

Published:2015-04 Issue:4 Volume:42 Page:355-359
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Chiaravalloti Agostino^ORCID,Fiorentini Alessandro,Villani Veronica,Carapella Carmine,Pace Andrea,Di Pietro Barbara,Di Russo Carmen,Palumbo Barbara,Floris Roberto,Schillaci Orazio

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference17 articles.

1. Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT;Calabria;Nucl Med Commun,2012

2. 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT;Karunanithi;Eur J Nucl Med Mol Imaging,2013

3. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization;Vallabhajosula;Semin Nucl Med,2007

4. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience;Ledezma;Eur J Radiol,2009

5. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas;Tripathi;Clin Nucl Med,2009

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASL, DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment changes;La radiologia medica;2024-08-08

2. 18F-DOPA;Radiopharmaceuticals;2024

3. Clinical Applications of TSPO PET for Glioma Imaging: Current Evidence and Future Perspective—A Systematic Review;Diagnostics;2023-05-21

4. PET radiotracers in glioma: a review of clinical indications and evidence;Clinical and Translational Imaging;2022-08-27

5. Imaging Findings of 18F-Choline and 18F-DOPA PET/MRI in a Case of Glioblastoma Multiforme Pseudoprogression: Correlation with Clinical Outcome;Nuclear Medicine and Molecular Imaging;2022-06-29